Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Political Press Watch.
Press releases published on June 2, 2025

Castellum, Inc. to Participate in the “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow” Virtual Conference Presented by Maxim Group LLC on Tuesday, June 3rd – Thursday, June 5th at 9:00 a.m. EDT
VIENNA, Va., June 02, 2025 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE-American: CTM) announces that its Chief Executive Officer, Glen Ives, has been invited to present at the “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow,” …

Life360 Proposes Convertible Senior Notes Offering
SAN FRANCISCO, June 02, 2025 (GLOBE NEWSWIRE) -- Life360, Inc. (“Life360” or the “Company”) (NASDAQ: LIF, ASX: 360), today announced its intention to offer, subject to market and other conditions, $250 million aggregate principal amount of convertible …

Atos Group receives confirmatory offer from the French State to acquire part of its former Advanced Computing business
Press release Atos Group receives confirmatory offer from the French State to acquire part of its former Advanced Computing business Vision AI activities excluded from the transaction Confirmatory offer received from the French State to acquire Eviden’s …

Le groupe Atos reçoit une offre ferme de l'Etat français pour l'acquisition d'une partie de son ancienne activité de Calcul Avancé
Le groupe Atos reçoit une offre ferme de l'Etat français pour l'acquisition d'une partie de son ancienne activité de Calcul Avancé Les Activités de Vision AI sont exclues de la transaction Offre ferme reçue de l'Etat français pour l'acquisition de l' …
![Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]](/images/pressrelease-small.png)
Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]
Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE WYOST® (denosumab-bbdz) and Jubbonti® (denosumab-bbdz) are first and only FDA-approved interchangeable denosumab biosimilars available in US Improves access for patients …

UPDATE: Texas Hemp Industry Urges Governor Abbott to Veto SB 3 in Emergency Press Conference
Editor's Note: The time of the press conference has been updated to 9:30 a.m. CST. All other details remain the same. Farmers, Veterans, Small Business Owners and Hemp Advocates to Speak Out Against Bill’s Threat to Jobs, Economic Growth and Freedom of …